595 related articles for article (PubMed ID: 34548411)
1. High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19.
Lourda M; Dzidic M; Hertwig L; Bergsten H; Palma Medina LM; Sinha I; Kvedaraite E; Chen P; Muvva JR; Gorin JB; Cornillet M; Emgård J; Moll K; García M; Maleki KT; Klingström J; Michaëlsson J; Flodström-Tullberg M; Brighenti S; Buggert M; Mjösberg J; Malmberg KJ; Sandberg JK; Henter JI; Folkesson E; Gredmark-Russ S; Sönnerborg A; Eriksson LI; Rooyackers O; Aleman S; Strålin K; Ljunggren HG; Björkström NK; Svensson M; Ponzetta A; Norrby-Teglund A; Chambers BJ;
Proc Natl Acad Sci U S A; 2021 Oct; 118(40):. PubMed ID: 34548411
[TBL] [Abstract][Full Text] [Related]
2. A Granulocytic Signature Identifies COVID-19 and Its Severity.
Vitte J; Diallo AB; Boumaza A; Lopez A; Michel M; Allardet-Servent J; Mezouar S; Sereme Y; Busnel JM; Miloud T; Malergue F; Morange PE; Halfon P; Olive D; Leone M; Mege JL
J Infect Dis; 2020 Nov; 222(12):1985-1996. PubMed ID: 32941618
[TBL] [Abstract][Full Text] [Related]
3. The Systemic Immune Response in COVID-19 Is Associated with a Shift to Formyl-Peptide Unresponsive Eosinophils.
Koenderman L; Siemers MJ; van Aalst C; Bongers SH; Spijkerman R; Bindels BJJ; Giustarini G; van Goor HMR; Kaasjager KAH; Vrisekoop N
Cells; 2021 May; 10(5):. PubMed ID: 34062964
[TBL] [Abstract][Full Text] [Related]
4. Characterization of low-density granulocytes in COVID-19.
Cabrera LE; Pekkarinen PT; Alander M; Nowlan KHA; Nguyen NA; Jokiranta S; Kuivanen S; Patjas A; Mero S; Pakkanen SH; Heinonen S; Kantele A; Vapalahti O; Kekäläinen E; Strandin T
PLoS Pathog; 2021 Jul; 17(7):e1009721. PubMed ID: 34228753
[TBL] [Abstract][Full Text] [Related]
5. Basophils and Mast Cells in COVID-19 Pathogenesis.
Murdaca G; Di Gioacchino M; Greco M; Borro M; Paladin F; Petrarca C; Gangemi S
Cells; 2021 Oct; 10(10):. PubMed ID: 34685733
[TBL] [Abstract][Full Text] [Related]
6. Behavior of Eosinophil Counts in Recovered and Deceased COVID-19 Patients over the Course of the Disease.
Cortés-Vieyra R; Gutiérrez-Castellanos S; Álvarez-Aguilar C; Baizabal-Aguirre VM; Nuñez-Anita RE; Rocha-López AG; Gómez-García A
Viruses; 2021 Aug; 13(9):. PubMed ID: 34578258
[TBL] [Abstract][Full Text] [Related]
7. High dimensional profiling identifies specific immune types along the recovery trajectories of critically ill COVID19 patients.
Penttilä PA; Van Gassen S; Panovska D; Vanderbeke L; Van Herck Y; Quintelier K; Emmaneel A; Filtjens J; Malengier-Devlies B; Ahmadzadeh K; Van Mol P; Borràs DM; Antoranz A; Bosisio FM; Wauters E; Martinod K; Matthys P; Saeys Y; Garg AD; Wauters J; De Smet F;
Cell Mol Life Sci; 2021 Apr; 78(8):3987-4002. PubMed ID: 33715015
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic alteration of low-density granulocytes in people with pulmonary post-acute sequalae of SARS-CoV-2 infection.
Dean LS; Devendra G; Jiyarom B; Subia N; Tallquist MD; Nerurkar VR; Chang SP; Chow DC; Shikuma CM; Park J
Front Immunol; 2022; 13():1076724. PubMed ID: 36591237
[TBL] [Abstract][Full Text] [Related]
9. Increased Complement Receptor-3 levels in monocytes and granulocytes distinguish COVID-19 patients with pneumonia from those with mild symptoms.
Gupta R; Gant VA; Williams B; Enver T
Int J Infect Dis; 2020 Oct; 99():381-385. PubMed ID: 32771640
[TBL] [Abstract][Full Text] [Related]
10. Sex differences in immune responses to SARS-CoV-2 in patients with COVID-19.
Zhao G; Xu Y; Li J; Cui X; Tan X; Zhang H; Dang L
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33350432
[TBL] [Abstract][Full Text] [Related]
11. Immunological imprint of COVID-19 on human peripheral blood leukocyte populations.
Kratzer B; Trapin D; Ettel P; Körmöczi U; Rottal A; Tuppy F; Feichter M; Gattinger P; Borochova K; Dorofeeva Y; Tulaeva I; Weber M; Grabmeier-Pfistershammer K; Tauber PA; Gerdov M; Mühl B; Perkmann T; Fae I; Wenda S; Führer H; Henning R; Valenta R; Pickl WF
Allergy; 2021 Mar; 76(3):751-765. PubMed ID: 33128792
[TBL] [Abstract][Full Text] [Related]
12. High Levels of Circulating IL-8 and Soluble IL-2R Are Associated With Prolonged Illness in Patients With Severe COVID-19.
Ma A; Zhang L; Ye X; Chen J; Yu J; Zhuang L; Weng C; Petersen F; Wang Z; Yu X
Front Immunol; 2021; 12():626235. PubMed ID: 33584733
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous NLRP3 inflammasome signature in circulating myeloid cells as a biomarker of COVID-19 severity.
Courjon J; Dufies O; Robert A; Bailly L; Torre C; Chirio D; Contenti J; Vitale S; Loubatier C; Doye A; Pomares-Estran C; Gonfrier G; Lotte R; Munro P; Visvikis O; Dellamonica J; Giordanengo V; Carles M; Yvan-Charvet L; Ivanov S; Auberger P; Jacquel A; Boyer L
Blood Adv; 2021 Mar; 5(5):1523-1534. PubMed ID: 33683342
[TBL] [Abstract][Full Text] [Related]
14. Innate cell profiles during the acute and convalescent phase of SARS-CoV-2 infection in children.
Neeland MR; Bannister S; Clifford V; Dohle K; Mulholland K; Sutton P; Curtis N; Steer AC; Burgner DP; Crawford NW; Tosif S; Saffery R
Nat Commun; 2021 Feb; 12(1):1084. PubMed ID: 33597531
[TBL] [Abstract][Full Text] [Related]
15. Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients.
Martín-Sánchez E; Garcés JJ; Maia C; Inogés S; López-Díaz de Cerio A; Carmona-Torre F; Marin-Oto M; Alegre F; Molano E; Fernandez-Alonso M; Perez C; Botta C; Zabaleta A; Alcaide AB; Landecho MF; Rua M; Pérez-Warnisher T; Blanco L; Sarvide S; Vilas-Zornoza A; Alignani D; Moreno C; Pineda I; Sogbe M; Argemi J; Paiva B; Yuste JR
Front Immunol; 2021; 12():659018. PubMed ID: 34012444
[TBL] [Abstract][Full Text] [Related]
16. Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks.
Ruhl L; Pink I; Kühne JF; Beushausen K; Keil J; Christoph S; Sauer A; Boblitz L; Schmidt J; David S; Jäck HM; Roth E; Cornberg M; Schulz TF; Welte T; Höper MM; Falk CS
Signal Transduct Target Ther; 2021 Dec; 6(1):418. PubMed ID: 34893580
[TBL] [Abstract][Full Text] [Related]
17. Systemic and mucosal mobilization of granulocyte subsets during lentiviral infection.
Jones R; Manickam C; Ram DR; Kroll K; Hueber B; Woolley G; Shah SV; Smith S; Varner V; Reeves RK
Immunology; 2021 Oct; 164(2):348-357. PubMed ID: 34037988
[TBL] [Abstract][Full Text] [Related]
18. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
[TBL] [Abstract][Full Text] [Related]
19. The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome.
Blot M; Bour JB; Quenot JP; Bourredjem A; Nguyen M; Guy J; Monier S; Georges M; Large A; Dargent A; Guilhem A; Mouries-Martin S; Barben J; Bouhemad B; Charles PE; Chavanet P; Binquet C; Piroth L;
J Transl Med; 2020 Dec; 18(1):457. PubMed ID: 33272291
[TBL] [Abstract][Full Text] [Related]
20. High levels of SARS-CoV-2-specific T cells with restricted functionality in severe courses of COVID-19.
Schub D; Klemis V; Schneitler S; Mihm J; Lepper PM; Wilkens H; Bals R; Eichler H; Gärtner BC; Becker SL; Sester U; Sester M; Schmidt T
JCI Insight; 2020 Oct; 5(20):. PubMed ID: 32937615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
